These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12396737)

  • 21. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes.
    De Rosa G; Quaglia F; La Rotonda MI; Appel M; Alphandary H; Fattal E
    J Pharm Sci; 2002 Mar; 91(3):790-9. PubMed ID: 11920765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodegradable microparticles for the controlled delivery of oligonucleotides.
    De Rosa G; Quaglia F; La Rotonda M; Besnard M; Fattal E
    Int J Pharm; 2002 Aug; 242(1-2):225-8. PubMed ID: 12176251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PLG microsphere size controls drug release rate through several competing factors.
    Berkland C; Kim K; Pack DW
    Pharm Res; 2003 Jul; 20(7):1055-62. PubMed ID: 12880292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of in vitro and in vivo release characteristics of sustained release ofloxacin microspheres.
    Abazinge M; Jackson T; Yang Q; Owusu-Ababio G
    Drug Deliv; 2000; 7(2):77-81. PubMed ID: 10892407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
    Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: phase-separation, degradation and release behavior.
    Mi FL; Lin YM; Wu YB; Shyu SS; Tsai YH
    Biomaterials; 2002 Aug; 23(15):3257-67. PubMed ID: 12102197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered PLGA microspheres for extended release of brexpiprazole:
    Wu B; Wu L; He Y; Yin Z; Deng L
    Drug Dev Ind Pharm; 2021 Jun; 47(6):1001-1010. PubMed ID: 34032181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adsorption of salmon calcitonin to PLGA microspheres.
    Calis S; Jeyanthi R; Tsai T; Mehta RC; DeLuca PP
    Pharm Res; 1995 Jul; 12(7):1072-6. PubMed ID: 7494805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
    J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
    He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of shaking and surfactants on the release of bsa from plga microspheres.
    Hernádez RM; Igartua M; Gascón AR; Calvo MB; Pedraz JL
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):92-6. PubMed ID: 9725463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of a novel approach to prepare biodegradable polylactic-co-glycolic acid microspheres: surface liquid spraying.
    Tang H; Xu N; Meng J; Wang C; Nie SF; Pan WS
    Yakugaku Zasshi; 2007 Nov; 127(11):1851-62. PubMed ID: 17978561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution.
    Raman C; Berkland C; Kim K; Pack DW
    J Control Release; 2005 Mar; 103(1):149-58. PubMed ID: 15773062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release.
    Goraltchouk A; Scanga V; Morshead CM; Shoichet MS
    J Control Release; 2006 Jan; 110(2):400-407. PubMed ID: 16325953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate).
    Kempen DH; Lu L; Kim C; Zhu X; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2006 Apr; 77(1):103-11. PubMed ID: 16392139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential applications of PLGA film-implants in modulating in vitro drugs release.
    Dorta MJ; Santoveña A; Llabrés M; Fariña JB
    Int J Pharm; 2002 Nov; 248(1-2):149-56. PubMed ID: 12429469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysozyme microencapsulation within biodegradable PLGA microspheres: urea effect on protein release and stability.
    Nam YS; Song SH; Choi JY; Park TG
    Biotechnol Bioeng; 2000 Nov; 70(3):270-7. PubMed ID: 10992231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel in vitro release technique for peptide containing biodegradable microspheres.
    Kostanski JW; DeLuca PP
    AAPS PharmSciTech; 2000 Mar; 1(1):E4. PubMed ID: 14727853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems.
    Igartua M; Hernández RM; Esquisabel A; Gascon AR; Calvo MB; Pedraz JL
    J Microencapsul; 1997; 14(3):349-56. PubMed ID: 9147284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.